Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

DexCom Q1 2024 Adj EPS $0.32 Beats $0.27 Estimate, Sales $921.000M Beat $909.238M Estimate

Author: Benzinga Newsdesk | April 25, 2024 04:04pm
DexCom (NASDAQ:DXCM) reported quarterly earnings of $0.32 per share which beat the analyst consensus estimate of $0.27 by 18.52 percent. The company reported quarterly sales of $921.000 million which beat the analyst consensus estimate of $909.238 million by 1.29 percent. This is a 24.21 percent increase over sales of $741.500 million the same period last year.

Posted In: DXCM


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist